...
首页> 外文期刊>Neuromuscular disorders: NMD >Early infantile sensory-motor neuropathy with late onset respiratory distress
【24h】

Early infantile sensory-motor neuropathy with late onset respiratory distress

机译:早期婴幼儿感觉运动神经病伴迟发性呼吸窘迫

获取原文
获取原文并翻译 | 示例
           

摘要

Children with spinal muscular atrophy with respiratory distress (SMARD1) usually present within their first year of life, with respiratory failure due to diaphragmatic paralysis and progressive distal limb weakness. We present a child with a confirmed compound heterozygous IGHMBP2 mutation c.[676G>T];[2083A>T] in whom severe sensory-motor neuropathy preceded diaphragmatic paralysis by almost 3. years. Autonomic system involvement with neurogenic bladder and urine retention were found at 3. years. In summary, our patient highlights the broad spectrum of phenotypes observed in SMARD1. Currently, no prediction of phenotype according to genotype is possible, suggesting that yet unknown factors cause the observed phenotypic variation. Even in the absence of obvious diaphragmatic weakness, SMARD1 should be considered in severe infantile onset neuropathies. High throughput techniques, such as next generation sequencing, will possibly offer a useful approach in the heterogeneous group of inherited neuropathies.
机译:伴有呼吸窘迫(SMARD1)的脊髓性肌萎缩症患儿通常在生命的第一年出现,由于,肌麻痹和进行性远端肢体无力而导致呼吸衰竭。我们介绍了一个儿童,该儿童已证实具有复合杂合的IGHMBP2突变c。[676G> T]; [2083A> T],其中严重的感觉运动神经病在diaphragm肌麻痹之前发生了将近3年。 3年时发现自主系统参与神经源性膀胱和尿retention留。总之,我们的患者强调了在SMARD1中观察到的广泛的表型。目前,尚无法根据基因型预测表型,这表明尚有未知因素导致观察到的表型变异。即使没有明显的diaphragm肌无力,也应考虑将SMARD1用于严重的婴儿发作性神经病。诸如下一代测序之类的高通量技术可能会在异类遗传性神经病中提供有用的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号